Related Experiment Videos
Expression of CD44 abnormal transcripts in human gastric carcinomas
H Yokozaki1, R Ito, H Nakayama
1First Department of Pathology, Hiroshima University School of Medicine, Japan.
Cancer Letters
|August 15, 1994
Summary
CD44 aberrant transcripts are overexpressed in gastric cancer, aiding diagnosis. Different expression patterns suggest distinct genetic pathways for well-differentiated versus poorly differentiated gastric carcinomas.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- CD44 gene is implicated in cancer progression.
- Aberrant CD44 splice variants are found in various cancers.
- Gastric cancer exhibits diverse histological subtypes with potentially different molecular underpinnings.
Purpose of the Study:
- To investigate the presence and significance of CD44 aberrant transcripts in gastric carcinoma.
- To determine if CD44 variant expression can differentiate gastric cancer subtypes.
- To explore the diagnostic potential of CD44 aberrant transcripts in gastric cancer.
Main Methods:
- Studied 20 gastric carcinoma cases.
- Utilized cDNA/PCR/blot-hybridization to detect CD44 aberrant transcripts, specifically those with aberrant exon 11.
- Compared transcript expression in tumor tissues, metastatic foci, and normal gastric mucosa.
Main Results:
- All tumor tissues and metastases showed CD44 splice variant overexpression compared to normal mucosa.
- Well-differentiated gastric cancers (66.7%) overexpressed >3 aberrant transcripts.
- Poorly differentiated gastric cancers (90.9%) overexpressed 1-2 lower molecular weight variants.
Conclusions:
- CD44 aberrant transcript detection is a valuable tool for gastric cancer diagnosis.
- Distinct CD44 variant expression patterns suggest different genetic pathways for gastric cancer subtypes.
- Further research into CD44's role could refine gastric cancer classification and treatment.